Management of pregnancies complicated by anti-Fya alloimmunization

Transfusion

Volumn 47, Issue 10, 2007, Pages 1858-1861

  Hughes, Laura H ^a   Rossi, Karen Q ^a   Krugh, David W ^a   O'Shaughnessy, Richard W ^a  

^a 561 Means Hall ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTIGEN; FY A ANTIBODY; FY A ANTIGEN; MATERNAL ANTIBODY; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ALLOIMMUNIZATION; ANTIBODY TITER; ARTICLE; BLOOD GROUP DUFFY SYSTEM; CLINICAL ARTICLE; EXCHANGE BLOOD TRANSFUSION; FEMALE; FETAL THERAPY; FETUS; FETUS HYDROPS; HEMOLYTIC ANEMIA; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; NEWBORN; OPTICAL DENSITY; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME;

ADULT; DUFFY BLOOD-GROUP SYSTEM; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; GESTATIONAL AGE; HEMOGLOBINS; HUMANS; INFANT, NEWBORN; ISOANTIGENS; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES;

EID: 34548808094     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01408.x     Document Type: Article

References (22)

1. Jackson M, Branch DW. Alloimmunization in pregnancy. In : Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 4th ed. New York : Churchill Livingstone 2002. p. 8 93 929.
2. Pepperell RJ, Barrie JU, Fliegner JR. Significance of red-cell irregular antibodies in the obstetric patient. Med J Aust 1977 2 : 453 6.
3. Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995 74 : 687 92.
4. Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997 89 : 272 5.
5. Jovanovic-Srzentic S, Djokic M, Tijanic N, Djordjevic R, Rizvan N, Plecas D, Filimonovic D. Antibodies detected in samples from 21,730 pregnant women. Immunohematology 2003 19 : 89 92.
6. Kornstad L. New cases of irregular blood group antibodies other than anti-D in pregnancy: frequency and clinical significance. Acta Obstet Gynecol Scand 1983 62 : 431 6.
7. Moise KJ Jr. Hemolytic disease of the fetus and newborn. In : Creasy RK, Resnik R, Iams JD, editors. Maternal-fetal medicine: principles and practice. 5th ed. Philadelphia : Saunders 2004. p. 5 37 61.
8. Management of isoimmunization in pregnancy. ACOG Educational Bulletin 227. Washington (DC) : American College of Obstetricians and Gynecologists 1996.
9. De Young-Owens A, Kennedy M, Rose RL, Boyle J, O'Shaughnessy R. Anti-M isoimmunization: management and outcome at the Ohio State University from 1969 to 1995. Obstet Gynecol 1997 90 : 962 6.
10. McKenna DS, Nagaraja HN, O'Shaughnessy R. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 1999 93 : 667 73.
11. Hackney DN, Knudtson EJ, Rossi KQ, Krugh D, O'Shaughnessy RW. Management of pregnancies compli cated by anti-c isoimmunization. Obstet Gynecol 2004 103 : 24 30.
12. Joy SD, Rossi KQ, Krugh D, O'Shaughnessy RW. Management of pregnancies complicated by anti-E alloimmunization. Obstet Gynecol 2005 105 : 24 8.
13. Brecher M, editor. Technical manual. 14th ed. Arlington (VA) : American Association of Blood Banks 2002.
14. Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by Rhesus sensitization. Am J Obstet Gynecol 1961 82 : 1359 70.
15. O'Shaughnessy R. Amniotic fluid spectraphotometry is useful after 20 weeks gestation in the care of pregnancies complicated by red blood cell isoimmunization [Abstract 256]. Am J Obstet Gynecol 1991 164 : 317.
16. O'Shaughnessy R, Kennedy M. Isoimmunization. In : Ling FW, Duff P, editors. Obstetrics and gynecology: principles for practice. New York : McGraw-Hill 2001. p. 3 08 26.
17. Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Grant SS, Widness JA. Management of fetal hemolytic disease by cordocentesis. I. Prediction of anemia. Am J Obstet Gynecol 1991 165 : 546 53.
18. Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Widness JA, Grant SS, Estle L. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment. Am J Obstet Gynecol 1991 165 : 1302 7.
19. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ, Dorman KF, Ludomirsky A, Gonzalez R, Gomez R, Oz U, Detti L, Copel JA, Bahado-Singh R, Berry S, Martinez-Poyer J, Blackwell SC. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000 342 : 9 14.
20. a. Am J Obstet Gynecol 1975 121 : 643 5.
21. Goodrick MJ, Hadley AG, Poole G. Haemolytic disease of the fetus and newborn due to anti-Fya and the potential value of Duffy genotyping in pregnancies at risk. Transfus Med 1997 7 : 301 4.
22. Oepkes D, Seaward PG, Vandenbussche FP, Windrim R, Kingdom J, Beyene J, Kanhai HH, Ohlsson A, Ryan G DIAMOND Study Group. Doppler sonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006 355 : 156 64.